Skip to content

Author

Emanuela Esposito

We have 6 of 85 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Comparative Adverse Event Reporting Patterns of Amoxicillin and Amoxicillin/Clavulanic Acid in FAERS: A 2022–2025 Disproportionality Analysis

Amoxicillin, alone or combined with clavulanic acid, is widely used for the treatment of bacterial infections. While clavulanic acid expands amoxicillin's antibacterial spectrum by inhibiting β‐lactamases, differences in their real‐world safety profiles and reporting patterns remain relevant for pharmacovigilance and a...

P. Irrera, Ilaria Ammendolia, Gabriella Frattima et al. · 0 citations
Open access Oct 2026

CCR1 Antagonism by BX471 Attenuates Neuroinflammation and Apoptosis: Preliminary Findings From an In Vitro Model of Neuronal Injury

ABSTRACT Neuronal injury as traumatic brain injury (TBI) triggers a complex pathophysiological cascade involving inflammatory and apoptosis processes. BX471 is a selective C‐C chemokine receptor type 1 (CCR1) antagonist that showed a promising effect in modulating neuroinflammation in central nervous system (CNS) disor...

Ahmed Hasan, Deborah Mannino, S. Scuderi et al. · 0 citations
Review Open access Sep 2026

The Role of Mast Cells and Their Potential as a Therapeutic Target For Neuroinflammation

Abstract Neuroinflammation is increasingly recognized as a central mechanism underlying the onset and progression of numerous neurological disorders, including neurodegenerative, autoimmune, and cerebrovascular diseases. Although microglia and astrocytes are traditionally considered the primary mediators of inflammator...

S. Scuderi, R. Basilotta, L. Cucinotta et al. · 0 citations
Review Open access Sep 2026

Mechanisms of resistance to PARP inhibitors in advanced epithelial ovarian cancer: biological determinants and therapeutic implications

PARP inhibitors have become an integral component of treatment strategies for advanced epithelial ovarian cancer, particularly in BRCA1/2-mutated and homologous recombination-deficient (HRD) tumors. Despite clinically meaningful improvements in progression-free survival, a substantial proportion of patients develop pri...

D. Incognito, G. Ciappina, G. Ettore et al. · 0 citations
Review Open access Sep 2026

Clinical, biochemical and genetic spectra of carnosinemia: a systematic review of case reports and case series

The available case reports highlight marked clinical heterogeneity in carnosinemia, ranging from severe neurodevelopmental phenotypes to asymptomatic biochemical abnormalities, which underscores the need for improved phenotypic characterization, systematic follow-up, and international case registries.

Giuseppe Carota, Alessio Ardizzone, L. Buccarello et al. · 0 citations
Open access Jan 2026

Tempol Ameliorates Psoriatic Skin Inflammation: Evidence of TLR4/NF‐κB/Nrf2 Axis Modulation

Tempol preserved tissue viability under psoriasiform conditions and significantly reduced Staphylococcus aureus (S. aureus) adhesion, and restored epidermal barrier integrity, as demonstrated by increased levels of tight junction and differentiation markers, even under infection‐associated conditions.

S. Scuderi, M. Lanza, A. Capra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.